Abstract
Rotavirus is the most common cause of severe gastroenteritis in young children worldwide. The introduction of vaccination programs has led to a significant reduction in number of hospitalizations due to rotavirus in North and South American countries. Little work has been done, however, to examine the differential impact of vaccination as a function of strain distribution and strain-specific vaccine efficacy. We developed a two-strain epidemiological model of rotavirus transmission, and used it to examine the effects of a monovalent vaccine (Rotarix) on the qualitative behaviors of infection levels in a population. For contrast, we parameterized our model with strain distribution data from North America and from South America. In all cases, the introduction of the vaccine led to significant decreases in the prevalence of primary infection due to both strains for a decade or more, after which the overall prevalence recovers to near pre-vaccination levels. The prevalence of G1P[8] is significantly higher in North America (73 % of all rotavirus infections) compared to that in South America (34 %). Our model predicts that the introduction of Rotarix might result in major strain replacement in regions such as North America where the prevalence of G1P[8] is relatively high, due to higher efficacy of Rotarix against infection caused by G1P[8], while regions with lower prevalence of G1P[8], such as South America, are not susceptible to major strain replacement.
Similar content being viewed by others
References
Atchison C, Lopman B, Edmunds WJ (2010) Modeling the seasonality of rotavirus disease and the impact of vaccination in England and Wales. Vaccine 28(18):3118–3126
Atkins KE, Shim E, Pitzer VE, Galvani AP (2012) Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine 30(3):552–564
Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP (2012) The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine 30(48):6766–6776
Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T, Taniguchi K et al (1986) Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 2(8504):417–421
Clarke E, Desselberger U (2015) Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol 8(1):1–17
de Blasio BF, Kasymbekova K, Flem E (2010) Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan. Vaccine 28(50):7923–7932
Dennehy PH (2008) Rotavirus vaccines: an overview. Clin Microbiol Rev 21(1):198–208
Ermentrout GB (2002) Simulating, analyzing, and animating dynamical systems: a guide to XPPAUT for researchers and students, 1st edn. Soc for Industrial & Applied Math, Philadelphia
Gentsch JR, Hull JJ, Teel EN, Kerin TK et al (2009) G and P types of circulating rotavirus strains in the United States during 1996–2005: nine years of prevaccine data. J Infect Dis 200:S99–105
Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J et al (2011) Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 365:337–346
Grimwood K, Lambert SB, Milne RJ (2010) Rotavirus infections and vaccines: burden of illness and potential impact of vaccination. Paediatr Drugs 12(4):235–256
Gurgel RQ, Alvarez ADJ, Rodrigues A, Ribeiro RR, Dolabella SS et al (2014) Incidence of rotavirus and circulating genotypes in northeast Brazil during 7 years of national rotavirus vaccination. PLoS One 9(10):e110217. doi:10.1371/journal.pone.0110217
Hull JJ, Teel EN, Kerin TK, Freeman MM et al (2011) United States rotavirus strain surveillance from 2005 to 2008 genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 30:S42–S47
Makela M, Marttila J, Simell O, Ilonen J (2004) Rotavirus-specific T-cell responses in young prospectively followed-up children. Clin Exp Immunol 137(1):173–178
Martcheva M, Bolker BM, Holt RD (2008) Vaccine-induced pathogen strain replacement: what are the mechanisms? J R Soc Interface 5:3–13
PATH (2013) Country introduction, maps and list. http://sites.path.org/rotavirusvaccine/country-introduction-maps-and-spreadsheet/
Payne DC, Wikswo M, Parashar UD (2012) Manual for the surveillance of vaccine-preventable diseases, Chapter 13: rotavirus. Centers for Disease Control and Prevention, Atlanta
Pitzer VE, Viboud C, Simonsen L, Steiner C, Panozzo CA, Alonso WJ et al (2009) Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 325(5938):290–294
Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ et al (2012) Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One 7(8):e42320. doi:10.1371/journal.pone.0042320
Pitzer VE, Viboud C, Lopman BA, Patel MM, Parashar UD, Grenfell BT (2011) Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. PNAS 108(48):19353–19358
Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354(1):11–22
Santos N, Hoshino Y (2005) Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15:29–56
Shim E, Banks HT, Castillo-Chavez C (2006) Seasonal pattern of rotavirus infection with its vaccination. Modeling the dynamics of human diseases: emerging paradigms and challenges. AMS Contemp Math Ser 410:327–348
Shim E, Feng Z, Martcheva M, Castillo-Chavez C (2006) An age-structured epidemic model of rotavirus with vaccination. J Math Biol 53:719–746
Shim E, Galvani AP (2009) Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine 27(30):4025–4030
Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD (2012) 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. doi:10.1016/S1473-3099(11)70253-5
van den Driessche P, Watmough J (2002) Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci 180:29–48
Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S et al (1996) Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335(14):1022–1028
Velazquez DE, Parashar UD, Jiang B (2014) Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: an overview. Infect Genet Evol 28:561–571
Ward RL, Bernstein DI, Shukla R, McNeal MM, Sherwood JR, Young EC et al (1990) Protection of adults rechallenged with a human rotavirus. J Infect Dis 161(3):440–445
Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM (1986) Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis 154(5):871–880
Weidemann F, Dehnert M, Koch J, Wichmann O, Hḧole M (2014) Modelling the epidemiological impact of rotavirus vaccination in Germany—a Bayesian approach. Vaccine 32:5250–5257
White LJ, Buttery J, Cooper B, Nokes DJ, Medley GF (2008) Rotavirus within day care centres in Oxfordshire, UK: characterization of partial immunity. J R Soc Interface R Soc 5(29):1481–1490
WHO. WHO UNICEF coverage estimates (2011). http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tswucoveragedtp1.htm
Wilde J, Yolken R, Willoughby R, Eiden J (1991) Improved detection of rotavirus shedding by polymerase chain reaction. Lancet 337(8737):323–326
Author information
Authors and Affiliations
Corresponding author
Appendix: Oscillation Analysis
Appendix: Oscillation Analysis
Numerical observations about the behavior of the system drive the study of the oscillations. First, the dynamics of the state variables \(Y_1\) and \(Y_2\) seen in Fig. 14a, b are slow relative to the dynamics of the infected states shown in Fig. 4a. Second, Fig. 14c shows that the variable H has relatively small changes in amplitude as it oscillates. Indeed, if the dynamics of H are frozen so that H is fixed at some intermediate value, the system still oscillates for a range of \(\beta _1\) and \(\beta _2\) values.
We therefore fix the value of H at an intermediate value and introduce a time-scaling parameter \(\tau _y\) to slow down the dynamics of \(Y_1\) and \(Y_2\) simultaneously. As \(\tau _y\) is decreased from 1 to 0, the period of the oscillation increases, and the system stops oscillating when \(\tau _y=0\); that is, oscillations vanish when the dynamics of \(Y_1\) and \(Y_2\) are completely turned off. When \(\tau _y\) is small, however, \(Y_1\) and \(Y_2\) remain (approximately) on a line with respect to one another, as seen in Fig. 15.
We exploit this observation by treating \(Y_1\) and \(Y_2\) as parameters, with the constraint that they both stay on the line \(Y_2=b+aY_2\), where a and b are approximated from Fig. 15.
Treating \(Y_1\) and \(Y_2\) as parameters in this way eliminates the oscillations in the system. Instead, the system is generically attracted to one of two steady states: one with strain 1 endemic and strain 2 extinct, the other with strain 2 endemic and strain 1 extinct, which we call \(E_1^*\) and \(E_2^*\), respectively. Figure 16 shows the stability of the two fixed points as the parameter \(Y_1\), and consequently \(Y_2\), varies. When \(Y_1\) is small, the \(E_1^*\) is stable and \(E_2^*\) is unstable. As \(Y_1\) increases past some critical threshold, the two steady states immediately switch stability: \(E_1^*\) becomes unstable and \(E_2^*\) becomes stable.
This instantaneous switch in the stability of the system is due to a degenerate hyperplane of fixed points at the critical value of \(Y_1\). In particular, at \(E_i^*\), we must have
which occurs if and only if
Equation (16) is satisfied if and only if
and by plugging (18) into (17), we get
If \(I_{ji}\not =0\), then \(\frac{dI_{0i}}{dt}=0\) and \(\frac{dI_{ji}}{dt}=0\) if and only if
or equivalently,
where \(S_i^*\) is the value of S at the fixed point \(E_i^*\). Thus, \(E_1^*\) and \(E_2^*\) coincide if and only if
In this case, \(I_{01}\), \(I_{02}\), \(I_{21}\) and \(I_{12}\) are all nonzero and from System (1) we have \(\frac{dS}{dt}=0\) if and only if
where \(\alpha _i=(\beta _i\rho S_i^*)/(\gamma _p+\mu -\beta _i S_i^*)\).
Setting equations (19) and (21) equal defines a line in the \(I_{21}\)-\(I_{12}\) plane, along which the reduced system is at a steady state. Since \(I_{0i}=\alpha _i I_{ji}\), the line of fixed points in the \(I_{21}\)-\(I_{12}\) plane defines a hyperplane of fixed points in \(I_{01}\)-\(I_{02}\)-\(I_{21}\)-\(I_{12}\) space.
This hyperplane exists only if equation (20) is satisfied. Given our requirement that \(Y_2=b+aY_1\), equation (20) is equivalent to
which, when evaluated at parameter values specified in our simulation, is exactly the bifurcation value of \(Y_1\) as in Fig. 16.
To visualize this bifurcation in System (1), we now allow \(Y_1\) and \(Y_2\) to vary as dynamic variables, but slow down their dynamics by a factor of \(\tau _y=0.01\) and continue to treat H as a parameter fixed at \(H=0.575\). Figure 17 shows the infected state \(I_{02}\) versus the susceptible class \(Y_1\). The vertical dashed line coincides with the critical value of \(Y_1\) from Fig. 16. Beginning in the lower left corner of the oscillation in Fig. 17, as \(Y_1\) increases through the critical value of \(Y_1\), the stability switches from strain 1 endemic to strain 2 endemic, and \(I_02\) quickly grows to a steady state. After \(I_{02}\) increases, \(Y_1\) begins to decrease again because all of the individuals who are susceptible to only strain 2 (i.e., individuals in class \(Y_1\)) quickly begin to become infected. Once \(Y_1\) decreases past the critical \(Y_1\) value, the incidence of strain 2 drops off sharply and \(Y_1\) begins to increase again.
In terms of a population, this means that while strain 1 is infecting a large proportion of the population, strain 2 is almost extinct. Consequently, much more individuals become infected with strain 1 than strain 2, and upon recovery, they are only susceptible to strain 2. The switch between strain 1 being the more prevalent strain to strain 2 taking over occurs when the number of individuals susceptible to only strain 2 surpasses a critical threshold. Immediately after the switch, there are much more individuals only susceptible to strain 2, but as these individuals become infected and recover, more will be susceptible to only strain 1, prompting another switch in the dominant strain back to strain 1, and the cycle repeats. The class of individuals who have recovered from strain i and are susceptible only to strain j are therefore the driving force behind the oscillations: Both strains require a sufficient number of susceptible individuals available only to that strain in order to infect a nontrivial proportion of the population. However, since the number of individuals who are susceptible to only strain 1 is inversely proportional to that of those susceptible to only strain 2, the two strains oscillate dominance over time.
Rights and permissions
About this article
Cite this article
Young, G., Shim, E. & Ermentrout, G.B. Qualitative Effects of Monovalent Vaccination Against Rotavirus: A Comparison of North America and South America. Bull Math Biol 77, 1854–1885 (2015). https://doi.org/10.1007/s11538-015-0107-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-015-0107-3